Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Laminate Medical

Explore full profile

Laminate Medical is a medical device

Tel Aviv-Yafo, IsraelFounded 2012Biotech & Life Sciences
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Laminate Medical and the history behind them.

About Laminate Medical

Laminate Medical Technologies, founded in 2012, focuses on addressing critical challenges in the use of fistulas for dialysis patients. A fistula is a connection made between an artery and a vein, usually in the arm, to facilitate dialysis treatment for patients with kidney failure. The company has developed innovative solutions to improve the success and usability of these fistulas, which are vital for the effective treatment of dialysis patients.

Read full description

Laminate Medical operates in the medical device industry, specifically targeting the nephrology market, which deals with kidney health and dialysis. Their primary clients include hospitals, dialysis centers, and healthcare providers who treat patients requiring dialysis. The company's flagship product, known as the "External Support," has been recognized for its potential to significantly enhance fistula performance and longevity. This product has even received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA), highlighting its innovative nature and potential impact on patient care.

The business model of Laminate Medical is centered around the development, manufacturing, and distribution of their medical devices. They generate revenue by selling these devices to healthcare institutions and providers. Additionally, they may engage in partnerships or licensing agreements with larger medical device companies to expand their market reach and enhance product development.

Laminate Medical's commitment to quality is evident through their adherence to international standards, such as ISO 13485, which ensures the quality and safety of medical devices. The company is led by experienced professionals with extensive backgrounds in the medical device industry, ensuring that their products meet the highest standards of efficacy and safety.

In summary, Laminate Medical Technologies is a pioneering company in the medical device sector, dedicated to improving the lives of dialysis patients through innovative solutions for fistula management.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2012
Headquarters
Tel Aviv-Yafo, Israel
Employees
37
Open positions
None listed
Dealroom signal
88.7/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, medical implants, Surgery, Kidney, Patient Care, Hospital, Tech for Hospitals and Clinics
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b, b2c

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Dec 2024 $15M $60M Undisclosed —
LATE VC✓Equity / VC Jun 2022 $4M $60M Undisclosed —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Laminate Medical website traffic

Latest recorded traffic for Laminate Medical is 4.5K monthly website visits, up 55.2% over the last three months. Laminate Medical's team grew 19.4% over the past year.

Latest monthly visits4.5K 3-month web change+55.2% 1-year team growth+19.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A8 investors entered at this stage

  • Haisco
  • Yehuda Zisapel
  • Eri Steimatzky
  • Zohar Gilon
  • Ari Raved
  • Henit Vitos
  • Nava
  • Champel Capital

Series B and later4 investors entered at this stage

  • Yuval Tal
  • Shai Agassi
  • Meir Barel
  • Tal Capital Group

Other known investors8 additional known investors

  • Akilia Partners
  • Beresford Ventures
  • RAD BioMed
  • Romain Afflelou
  • Tal Ventures
  • Valiance
  • Valiance Asset Management
  • YADAY
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States57.1%
🇮🇱 Israel10.7%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Laminate Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Laminate Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.